InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Hicks Laurence. Officer active across 1 company, notably Arch Therapeutics, Inc.. Aggregated, 2 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €3k. Activity tracked since 31 August 2023. The latest transaction was filed on 31 August 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations